PR Newswire: news distribution, targeting and monitoring
2014

Breckenridge Announces Approval of Anastrozole Tablets

Share with Twitter Share with LinkedIn

BOCA RATON, Fla., June 28 /PRNewswire/ -- Breckenridge Pharmaceutical, Inc. announced today that they will launch Anastrozole 1mg Tablets.  The U.S. Food and Drug Administration has granted final approval for the Abbreviated New Drug Application (ANDA) for this first time generic, which is being supplied under a licensing agreement. Anastrozole Tablets are AB rated to Arimidex®, a billion dollar cancer drug marketed by AstraZeneca.  Breckenridge will launch the product today.

About Breckenridge:

Breckenridge Pharmaceutical is a privately held pharmaceutical marketing, research and development company founded in 1983 that markets a broad range of Generic prescription products in many therapeutic categories; including several unique ValuBrand™ products. The Breckenridge label is recognized by Wholesalers, Distributors, Chains, and Managed Care Accounts, as well as Retail Pharmacies nationwide. The company markets multiple ANDA's, in a variety of dosage forms including: Tablets, Capsules, Soft Gel Capsules, Liquids, and Powders. Breckenridge was recently honored as a 50th Anniversary DIANA award winner for "Best Overall Generic Products Manufacturer" by the HDMA in October 2009. www.bpirx.com

SOURCE Breckenridge Pharmaceutical, Inc.



RELATED LINKS
http://www.bpirx.com

Featured Video

Journalists and Bloggers

Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.

View and download archived video content distributed by MultiVu on The Digital Center.

Share with Twitter Share with LinkedIn
 

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

 
 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

 
 

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.

 
Area to test

Online Member Center

Not a Member?
Click Here to Join
Login
Search News Releases
Advanced Search
Search
  1. PR Newswire Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
  5. Send a News Release